@ATPResearch

Welcome to Alberta's Tomorrow Project! This long-term cancer and chronic disease prevention study will follow its 55,000 participants for the next 50 years.

 Alberta, Canada
myatp.ca
Joined June 2010
  • Tweets2.1K
  • Following493
  • Followers737
210Media
New Priority Announcements (PAs) are available in the Spring 2024 Project Grant competition!🔍 We are funding PAs related to #BreastCancer, #CancerSurvivorship, and #CancerPrevention. Learn more: bit.ly/48MbNsG
CIHR
@CIHR_IRSC10 Jan 2024
📢Registration is now open for the Spring 2024 Project Grant competition: researchnet-recherchenet.ca/… We have reorganized the registration and application instructions to make them clearer and easier to follow.
1
5
1
4
1,248
ATP Research retweeted
CIHR
@CIHR_IRSC29 Nov 2023
Upcoming #FundingOpportunity! CIHR will soon be launching Operating Grants: Knowledge Mobilization in Diabetes Prevention and Treatment Details: cihr-irsc.gc.ca/e/53733.html
Funding Opportunity: Knowledge mobilization in diabetes prevention and treatment

ALT Funding Opportunity: Knowledge mobilization in diabetes prevention and treatment

14
3
10
3,293
ATP Research retweeted
CanPath@CanPath2 Nov 2023
Registration for the next CanPath trainee research webinar is live! Join @mp_harwood and Umaimah Zanif as they showcase how CanPath data can be used to explore how age, lifestyle factors, and the environment affect gene and biomarker expression. bit.ly/CanPathTraineeWebinar…
Trainee research webinar poster

ALT Trainee research webinar poster

4
2
5
1,042
ATP Research retweeted
CanPath@CanPath29 Nov 2023
1 in 2 Canadians will face a cancer diagnosis in their lifetime. It's a staggering statistic that hits home for so many. At CanPath, we're using data from over 330,000 Canadians to better understand cancer and, more importantly, predict it sooner. #EveryoneCounts
1
1
9
454
ATP Research retweeted
CanPath@CanPath27 Nov 2023
Why do some people remain healthier and live longer compared to those who develop a disease earlier on? 🤔 On Wed., Dec. 6 at noon EST, get inspired by two trainees' studies and learn more about how you can leverage CanPath data for your research! bit.ly/CanPathTraineeWebinar…
Trainee research webinar poster

ALT Trainee research webinar poster

6
6
693
ATP Research retweeted
YACC@yacancercanada20 Oct 2023
It takes longer to recover from cancer than to be treated for it, and we're conducting the Recover study to help us better understand the quality of life for Canadian young adults diagnosed with cancer over time. Visit recoverstudy.ca to learn more and sign up! #AYACSM
2
2
4
772
ATP Research retweeted
CanPath@CanPath31 Oct 2023
Our commitment to working in partnership to prevent cancers like breast cancer and provide a platform for scientists to conduct innovative research extends far beyond October. Join us in championing the cause all year round. Together, we can make a difference. #EveryoneCounts
Graphic displaying CanPath breast cancer treatment data. Over 7,800 Canadian participants within CanPath reported a breast cancer diagnosis, and more than 7,300 reported receiving treatment. 7,346 participants reported receiving any treatment, 6,407 participants reported having surgery, 5,044 participants reported having radiation, 3,510 participants reported having chemotherapy, and 1,359 reported receiving another treatment.

ALT Graphic displaying CanPath breast cancer treatment data. Over 7,800 Canadian participants within CanPath reported a breast cancer diagnosis, and more than 7,300 reported receiving treatment. 7,346 participants reported receiving any treatment, 6,407 participants reported having surgery, 5,044 participants reported having radiation, 3,510 participants reported having chemotherapy, and 1,359 reported receiving another treatment.

1
2
2
292
ATP Research retweeted
CanPath@CanPath25 Oct 2023
🚨#FundingOpportunity: @CIHR_IRSC's Healthy Cities Research Initiative's Operating Grant for Data Analysis Using Existing Databases & Cohorts is open! researchnet-recherchenet.ca/…
Hand holding a megaphone. Colourful hexagon design in background.

ALT Hand holding a megaphone. Colourful hexagon design in background.

2
3
1
4
471
ICR is supporting a Cancer Pool in Team Grant: Embracing Diversity to Achieve Precision & Health Equity. The pool focuses on heterogeneity in nutrition and metabolic health as they relate to cancer prevention or early detection of cancer. LOI deadline: February 1, 2024
1
3
4
532
What is the history of the Manitoba Tomorrow Project? 📈The MTP pilot project launched in 2017. 🌏Official recruitment began in 2018. 🧪Contributions to national COVID-19 research initiatives began in 2020. 🌞Our first ancillary project (@SunFit) began this summer.
1
2
1
3
401
ATP Research retweeted
CanPath@CanPath12 Oct 2023
We're one week away from Dr. Brooks' upcoming webinar on personalized approaches to Canadian breast cancer screening. Register today! 🖥️ Virtual via Zoom 🗓️ October 19, 12–1 pm EDT 🔗 bit.ly/CanPathBrooksWebinar #BreastCancerAwarenessMonth
Webinar banner

ALT Webinar banner

4
4
508
Here’s what Helene from Kitchener had to say about why she has continued to be a member of the Ontario Health Study since joining in 2013:
2
3
286
ATP Research retweeted
CanPath@CanPath14 Sep 2023
Calling all aspiring research operations managers: we're hiring! Join our team to drive CanPath’s objectives in enhancing & accelerating research for a healthier Canada. 🗓️ Apply by Sept. 22: jobs.utoronto.ca/job/Toronto…
Decorative banner with text reading "Now hiring. Research Operations Manager. Apply by Sept. 22 at jobs.utoronto.ca". Logo of CanPath (Canadian Partnership for Tomorrow's Health) in the bottom left corner.

ALT Decorative banner with text reading "Now hiring. Research Operations Manager. Apply by Sept. 22 at jobs.utoronto.ca". Logo of CanPath (Canadian Partnership for Tomorrow's Health) in the bottom left corner.

1
2
114
ATP Research retweeted
CanPath@CanPath15 Sep 2023
🙋 Are you interested in breast cancer awareness and prevention in Canada? Don't miss our upcoming webinar with Dr. Jennifer Brooks. In her research, she applies risk prediction tools to inform breast cancer screening. 🔗 bit.ly/CanPathBrooksWebinar
Dr. Jennifer Brooks webinar poster, showcasing personalized approaches to Canadian breast cancer screening

ALT Dr. Jennifer Brooks webinar poster, showcasing personalized approaches to Canadian breast cancer screening

5
6
428
ATP Research retweeted
CanPath@CanPath12 Sep 2023
Have you signed up for CanPath News, our quarterly newsletter? It features cohort and access updates, upcoming webinars, recent publications and more! Sign up today: bit.ly/CanPathNews
Text reads “CanPath NEWS” on a dark blue background with decorative colourful hexagons.

ALT Text reads “CanPath NEWS” on a dark blue background with decorative colourful hexagons.

3
4
308
ATP Research retweeted
CanPath@CanPath13 Sep 2023
🌟 Simultaneously, we're excited to welcome Dr. Jennifer Brooks as our new Executive Director. With expertise in epidemiology, genetics, and breast cancer research, she will lead CanPath into a new chapter of discovery and innovation. 👏👏
1
2
67
ATP Research retweeted
CanPath@CanPath13 Sep 2023
🎓 Please join us in congratulating Dr. John McLaughlin as he will soon retire as CanPath Executive Director. As he takes on the title of Professor Emeritus from @UofT, we thank him for his legacy in epidemiology and population health. 🔗 Read more: canpath.ca/2023/09/dr-mclaug…
Headshots of CanPath incoming and outgoing directors, Dr. John McLaughlin and Dr. Jennifer Brooks, respectively.

ALT Headshots of CanPath incoming and outgoing directors, Dr. John McLaughlin and Dr. Jennifer Brooks, respectively.

1
2
1
7
680
ATP Research retweeted
CanPath@CanPath15 Aug 2023
"...By last spring, 75 per cent of people across Canada had developed antibodies in response to COVID-19 infections." 📰 Read the full article on U of T News: utoronto.ca/news/u-t-researc…

U of T researchers contribute to Canada-wide COVID-19 immunity study

A new study involving researchers from the University of Toronto suggests that, by last spring, 75 per cent of people across Canada had developed antibodies in response to COVID-19 infections. Using...

utoronto.ca
University of Toronto@UofT15 Aug 2023
#UofT researchers contribute to Canada-wide COVID-19 immunity study 🔬 uoft.me/9y9
2
3
354
ATP Research retweeted
CMAJ@CMAJ14 Aug 2023
SARS-CoV-2: what were the trends in infection-acquired and vaccine-induced immunity in Canada? New articles this week on SARS-CoV-2 seroprevalence, minimally invasive procedures in gender-affirming care, delirium, and more ➡️ cmaj.ca/content/195/31 #MedTwitter
Text: Read the latest on SARS-CoV-2 seroprevalence, minimally invasive procedures in gender-affirming care, delirium, and more in Volume 195, Issue 31 of the CMAJ. Image: Graph of SARS-CoV-2 infection–acquired and vaccine-induced seroprevalence in Canada (March 2020 to March 2023)

ALT Text: Read the latest on SARS-CoV-2 seroprevalence, minimally invasive procedures in gender-affirming care, delirium, and more in Volume 195, Issue 31 of the CMAJ. Image: Graph of SARS-CoV-2 infection–acquired and vaccine-induced seroprevalence in Canada (March 2020 to March 2023)

4
3
853
ATP Research retweeted
CanPath@CanPath14 Aug 2023
🔬🦠 Boosting Immunity Insights: New research led by @COVIDimmunityTF, with contributions from CanPath, reveals Canada's evolving immunity landscape in the first pan-Canadian seroprevalence study! 🔗 canpath.ca/2023/08/covid-ser…

Boosting Immunity Insights: Collaborative Canadian Effort Contributes to Nationwide COVID-19...

TORONTO, Monday, August 14, 2023 – Today, CanPath (the Canadian Partnership for Tomorrow’s Health) has contributed to the first peer-reviewed publication showcasing pan-Canadian seroprevalence...

canpath.ca
CMAJ@CMAJ14 Aug 2023
SARS-CoV-2 seroprevalence: Most people in Canada were infected with SARS-CoV-2 for the first time during the Omicron era, after previously being vaccinated. Learn more (and earn CPD credits) ➡️ cmaj.ca/lookup/doi/10.1503/c… #COVID19
Given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.

ALT Given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.

1
8
11
2,754
Load more